Cagrilintide research supply
Review Cagrilintide in 5 mg, 10 mg, with 10 vials per box. Select the catalog code and pack specification for your wholesale inquiry. Our team confirms current availability, batch documentation and destination requirements.
Build your inquiry
Availability, packaging and pricing are confirmed by our team.Cagrilintide specifications and packaging
| Catalog code | Product / composition | Pack specification |
|---|---|---|
| CGL5 | Cagrilintide | 5 mg × 10 vials |
| CGL10 | Cagrilintide | 10 mg × 10 vials |
Each listed pack contains 10 vials. Select the catalog code and specification above, then add your box quantity to the inquiry.
Cagrilintide documentation
Contact our team to request the available COA and confirm documentation for your specification and proposed supply batch.
Request COA →Cagrilintide purchasing details
Select the catalog format
CGL5 and CGL10 are the standalone Cagrilintide catalog options. Specify the individual product and box count when it is part of a larger multi-product inquiry.
Quantity example: CGL5 lists 5 mg per vial and 10 vials per box. An inquiry for 2 boxes means 20 vials at 5 mg each. These are catalog label quantities, not batch assay results.
Vials or bulk raw material?
The quote selector on this page uses boxes of finished vials. For bulk raw-material requirements, specify the required total mass, material specification and container requirements separately; the vial pack does not establish a raw-material minimum order quantity.
Documents and quotation scope
Match the full material identity and any salt designation to the proposed batch. Request available identity and content documentation for the selected vial format. Use the COA review checklist to record the product, batch and test scope.
Send the selected code, box count, destination country and requested delivery date. Ask the quote to confirm availability, minimum quantity, preparation time, shipping service and cost. If custom labels or boxes are needed, include them in the packaging inquiry. Delivery timing and batch documents are confirmed for the proposed order. The supplier checklist covers the wider purchasing review.
PRODUCT IDENTITY & REFERENCE
Cagrilintide: modified peptide reference
The Cagrilintide reference includes a peptide chain, a lipid-bearing modification and a disulfide linkage. These features distinguish the complete molecule from an unmodified peptide backbone or a synthetic intermediate.
- Reference formula
- C194H312N54O59S2
- Reference molecular weight
- 4409 g/mol
- Reference record
- PubChem CID 171397054 ↗
Confirm the complete modified structure
Match the sequence, lipid attachment and disulfide connectivity in the material specification. A structure from a combination-product record should not be substituted for the single-component reference.
What to confirm for this catalog item
CGL5 and CGL10 are standalone Cagrilintide listings. No Semaglutide content or combination ratio is implied by those catalog codes; any combination must be specified separately.
Images and numerical properties describe the cited database forms, not batch test results. Confirm the actual supplied form against the specification. Molecular weights retain the precision reported by PubChem.
Related product details: Semaglutide · Retatrutide
Reference review: 28 September 2026. Pack details follow the catalog above; batch information is confirmed separately.